Bill Text: HI SCR42 | 2010 | Regular Session | Amended

---

Bill Title: Health Insurance; Drug Formularies; Drug Prior Authorization (SD1)

Spectrum: Partisan Bill (Democrat 4-0)

Status: (Engrossed - Dead) 2010-04-12 - (H) Referred to HLT/HUS/LAB, CPC, referral sheet 67 [SCR42 Detail]

Download: Hawaii-2010-SCR42-Amended.html

---

 

 

STAND. COM. REP. NO. 3089

 

Honolulu, Hawaii

                  

 

RE:    S.C.R. No. 42

       S.D. 2

 

 

 

Honorable Colleen Hanabusa

President of the Senate

Twenty-Fifth State Legislature

Regular Session of 2010

State of Hawaii

 

Madam:

 

     Your Committee on Commerce and Consumer Protection, to which was referred S.C.R. No. 42, S.D. 1, entitled:

 

"SENATE CONCURRENT RESOLUTION EXPRESSING SUPPORT FOR LOCAL ACCOUNTABILITY OF DRUG FORMULARIES AND DRUG PRIOR AUTHORIZATION POLICIES,"

 

begs leave to report as follows:

 

     The purpose of this measure is to demonstrate Legislative support for the maintenance of locally-based pharmacy and therapeutics committees to make decisions on drug formulary and drug prior authorization policies of all health insurance plans doing business in Hawaii, including those under contract with Hawaii Med-QUEST.

 

     Testimony in support of this measure was submitted by the Hawaii Medical Association.  Written testimony presented to the Committee may be reviewed on the Legislature's website.

 

     Your Committee finds that some Hawaii insurance plans are outsourcing determination of drug formularies and drug prior authorization policies to out-of-state pharmacy benefit managers.  This outsourcing is resulting in a decrease of Hawaii jobs and drug policies that are unreasonable and burdensome for doctors, pharmacies, and patients.  Your Committee further finds that these burdens are resulting in some doctors limiting acceptance of health insurance plans, which is negatively impacting patient access to care.

Your Committee hopes that locally-based pharmacy and therapeutics committees will be maintained to make decisions on drug formulary and drug prior authorization policies that reflect the practical and market realities of Hawaii.

 

     Your Committee has amended this measure by making technical, nonsubstantive changes to ensure clarity and accuracy in the language of this measure.

 

     As affirmed by the record of votes of the members of your Committee on Commerce and Consumer Protection that is attached to this report, your Committee concurs with the intent and purpose of S.C.R. No. 42, S.D. 1, as amended herein, and recommends its adoption in the form attached hereto as S.C.R. No. 42, S.D. 2.

 

Respectfully submitted on behalf of the members of the Committee on Commerce and Consumer Protection,

 

		____________________________ ROSALYN H. BAKER, Chair